Launch of Copaxone 20 mg can add Rs 8-10 to FY19 EPS for Natco: HDFC Securities News News / News 7 years ago 612 Views comments Natco Pharma rallies in trade as Mylan gets US Food and Drug Administration (US FDA) nod for Copaxone. In an interview to CNBC-TV18, Amey Chalke, Rese... Read more
News We want to help homebuyers get their flats or their money refunded: SC News / News - 7 years ago
News FICCI chief Pankaj Patel asks RBI to cut rates, labels policies as "anti-growth" News / News - 7 years ago
News India could soon have an Intellectual Property Exchange akin to Hong Kong, UK News / News - 7 years ago
News Uttar Pradesh government says mystery white powder not sent to Agra lab, insists it has PETN News / News - 7 years ago
News JPMorgan ups HDFC target price to Rs 1,975, sees minimal asset quality risk News / News - 7 years ago
Comments